Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,450 | -7,380 | -3,800 | -730 | -6,710 |
| Depreciation Amortization | 1,680 | 1,710 | 1,330 | 660 | 1,380 |
| Accounts receivable | 96 | N/A | N/A | N/A | -1,081 |
| Accounts payable and accrued liabilities | 678 | N/A | N/A | N/A | -1,183 |
| Other Working Capital | 1,460 | 220 | -940 | -2,190 | -2,100 |
| Other Operating Activity | -764 | 20 | 0 | -10 | 2,264 |
| Operating Cash Flow | $-7,300 | $-5,430 | $-3,410 | $-2,270 | $-7,430 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,435 | N/A | N/A | N/A | 14,813 |
| PPE Investments | -1,350 | -820 | -1,170 | -240 | -1,550 |
| Other Investing Activity | -15 | 1,190 | 360 | -1,070 | -3 |
| Investing Cash Flow | $3,070 | $370 | $-810 | $-1,310 | $13,260 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 615 | N/A | N/A | N/A | N/A |
| Debt Repayment | -54 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 96,307 | N/A | N/A | N/A | 766 |
| Other Financing Activity | -8 | 780 | 60 | 10 | -6 |
| Financing Cash Flow | $96,860 | $780 | $60 | $10 | $760 |
| Beginning Cash Position | 9,270 | 9,270 | 9,270 | 9,270 | 2,680 |
| End Cash Position | 101,910 | 5,000 | 5,110 | 5,710 | 9,270 |
| Net Cash Flow | $92,630 | $-4,270 | $-4,160 | $-3,560 | $6,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,300 | -5,430 | -3,410 | -2,270 | -7,430 |
| Capital Expenditure | -1,358 | N/A | N/A | N/A | -1,552 |
| Free Cash Flow | -8,658 | -5,430 | -3,410 | -2,270 | -8,982 |